| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $9,9690 | -0,71% | $317,37M | $29,61K | |
FUND Sprott Focus Trust, Inc. | $10,8050 | -0,69% | $317,19M | $449,00 | |
FATE Fate Therapeutics, Inc. | $2,3350 | +0,22% | $317,04M | $469,73K | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,6450 | +0,92% | $316,83M | $173,19K | |
GALT Galectin Therapeutics Inc. | $3,7490 | +1,88% | $316,66M | $42,97K | |
NREF NexPoint Real Estate Finance, Inc. | $17,5300 | +2,64% | $316,64M | $10,07K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8550 | +0,23% | $316,34M | $358,00 | |
PSBD Palmer Square Capital BDC Inc. | $10,3900 | +1,17% | $316,32M | $16,70K | |
| $3,2040 | -1,11% | $316,09M | $91,59K | |
| $6,4500 | -0,31% | $315,88M | $23,20K | |
SMTI Sanara MedTech Inc. Common Stock | $34,3500 | -0,29% | $315,59M | $102,43K | |
MLP Maui Land & Pineapple Co. | $15,8300 | +1,09% | $315,56M | $3,02K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9300 | +0,18% | $315,33M | $2,97K | |
| $41,2300 | +0,56% | $315,30M | $4,78K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5350 | +0,00% | $315,30M | $17,91K | |
